Shultz S L, Meriney D K
Dimens Crit Care Nurs. 1996 Jul-Aug;15(4):187-97.
The life expectancy of transplant patients has dramatically increased because of the development of cyclosporine to combat graft rejection. More recently, tacrolimus has been approved and is expected to further enhance survival. This paper compares these two medications and explores the role of the critical care nurse in monitoring outcomes and preventing side effects in patients with these immunosuppressants.
由于用于对抗移植排斥反应的环孢素的发展，移植患者的预期寿命显著提高。最近，他克莫司已获批准，预计将进一步提高生存率。本文比较了这两种药物，并探讨了重症护理护士在监测使用这些免疫抑制剂患者的治疗结果及预防副作用方面的作用。
